Results 171 to 180 of about 500,299 (305)

Mothers' Views and Experiences of Digital Maternal Presence Intervention and Skin-to-Skin Contact for Neonatal Pain Relief: A Qualitative Study. [PDF]

Nurs Open
Palomaa AK, Talus E, Keskitalo-Leskinen S, Pölkki T.   +3 more
europepmc   +1 more source

Maternal Stressor Agents with Premature Infants in Neonatal Intensive Care Units [PDF]

Introduction: Birth of a premature infant is associated with separation from family and hospitalizationActually, parents would undergo a lot of stress. The present study aimed to determine stressor agents of the mothers with premature infants admitted ...
مهرنوش, نسرین, سیدفاطمی, نعیمه, حقانی, حمید, بریم نژاد, لیلی   +3 more
core  

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

[Hydrops fetalis in infant newborn with congenital cytomegaly ].

Revista da Associacao Medica Brasileira (1992), 2003
Flávio Adolfo Costa, Vaz, Edna M Albuquerque, Diniz   +1 more
openaire   +1 more source

Optimal dosing for vascular anomalies paediatric patients with population pharmacokinetic model of sirolimus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Sirolimus is currently used off‐label for paediatric patients with vascular anomalies. However, the optimal dosage regimen for paediatric patients remains controversial. This study aimed to determine the optimal dosing regimen of sirolimus in these patients using a population pharmacokinetic (PK) model.
Seongmee Jeong, Jungryul Kim, Woojin Jung, Jiyeon Jeon, Hyeongjun Jo, Kyoung‐Bin Ryu, Ja‐Young Hong, Kwan Soo Kim, Seongjun Yang, Hee Young Ju, Hwi‐yeol Yun, Jung‐woo Chae, Keon Hee Yoo, Soyoung Lee   +13 more
wiley   +1 more source

Resuscitation of newborn infants and postnatal support of transition - An overview of the European Resuscitation Council guideline 2025. [PDF]

Z Geburtshilfe Neonatol
Mileder LP, Wagner M.
europepmc   +1 more source

[Nutritional requirements of the low birth-weight newborn infant]

, 1985
The preterm newborn infant for his very high growth rate is especially vulnerable to any deficiency or excess of the nutritional intake. Moreover he differs from the older infant because of the immaturity of many biological function.
DE CURTIS, MARIO, Senterre, J.
core  

Pregnancy‐related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis

British Journal of Clinical Pharmacology, EarlyView.
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas, Naim Bouazza, Frantz Foissac, Saïk Urien, Léo Froelicher‐Bournaud, Gabrielle Lui, Victoria Guillemart, Nicolas Carlier, Jennifer Da Silva, Johanna Fesenbeckh, Reem Kanaan, Isabelle Honoré, Clémence Martin, Jean‐Marc Treluyer, Vassilis Tsatsaris, Pierre‐Régis Burgel, Sihem Benaboud   +16 more
wiley   +1 more source

Newborn and infant hearing screening outcomes at a tertiary paediatric hospital in the Western Cape, South Africa. [PDF]

S Afr J Commun Disord
Kuschke S, Van Zyl C, Mokete M, Ramma L.
europepmc   +1 more source

Codeine toxicity via breast Milk: Can this occur and implications for opiate therapy in children

British Journal of Clinical Pharmacology, EarlyView.
Codeine is commonly used in combination analgesic products. The use of codeine during breastfeeding can rarely be associated with serious adverse effects related to genetic polymorphisms affecting codeine's metabolism and disposition. Clinicians treating infants of breastfeeding mothers should be aware of this rare but potentially serious complication.
Michael Rieder
wiley   +1 more source